Zhou Q, Wang X, Li R, Wang C, et al. Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis. J Gastroenterol 2022 Aug 3. pii: 10.1007/s00535-022-01910.
PMID: 35920933